Comparison of the effectiveness of ocrelizumab vs interferons, fingolimod and natalizumab on relapses in relapsing-remitting multiple sclerosis

---

ROOS I., SHARMİN S., OZAKBAŞ S., HORAKOVA D., Havrdova E., BOZ C., ...More

ECTRIMS, 13 - 15 October 2021, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Ondokuz Mayıs University Affiliated: Yes